Cosmetics/Skin Care Market Could Exceed US $750 Billion by 2025
Palm Beach, FL – April 30, 2020 – The global cosmetic skincare market and the cosmetic market are projected to continue substantial growth through the next several years. A report from Technavio projected that The global cosmetic skincare market size will grow by $38.03 billion during 2020-2024. The market’s growth momentum will accelerate during the […]
Pressure BioSciences, Through Cannaworx, Inc., Announces Letter of Intent to Acquire SkinScience Labs, Inc.
Accretive Acquisition Adds Profitable Award-Winning Dr. Denese Skin Care & Anti-Aging Lines, Which Generated Approximately $18 Million in Total Sales in 2019 and Over $500M in Sales on QVC Over the Last 17 Years South Easton, MA – April 30, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in […]
Canada’s Silicon Valley Is Leading A Tech Revolution
FN Media Group Presents Oilprice.com Market Commentary London – April 30, 2020 – High-tech mobility isn’t just about a ride. It’s about an experience, and the emerging poster-child in this space offers everything from a smooth, green ride and the most advanced technology to a tie-in to many things you need or want in […]
Despite Ups and Downs, Cannabis Market Still Projected To Reach $89 Billion by 2024
Palm Beach, FL – April 29, 2020 – It seems that as the global cannabis market continues to ebb and flow, its tentacles are reaching into traditionally unrelated markets such as cosmetics, biopharmaceuticals, food & agriculture and the beverages markets. The worldwide cosmetics market is projected at $758 billion by 2025; the global biopharmaceuticals market […]
Pressure BioSciences Announces Plans to Acquire Cannaworx, Inc.
Merger Combines Cannaworx’s Proprietary Portfolio of Innovative Consumer Products with the Application of PBI’s Breakthrough Ultra Shear Technology in the Pain Relief, Cosmeceuticals, Nutraceuticals, Pharmaceuticals, Agriculture, and Veterinary Fields South Easton, MA – April 29, 2020 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of […]
FDA Expediting Accelerated Development of Novel Therapies for COVID-19
Palm Beach, FL – April 28, 2020 – The U.S. Federal government is working closely with companies and researchers to find treatments and vaccines to overcome the global health crisis. The FDA has been cutting red tape and has launched new programs that relax certain time consuming regulations while still assuring the efficacy and safety […]
The $30 Trillion Trend That’s Bigger Than The Entire US Stock Market
FN Media Group Presents Oilprice.com Market Commentary London – April 24, 2020 – While the current market is trouncing traditional investment themes, sustainable investing–already a $30-trillion mega trend–is calling all the shots in a world where big money has realized one critical truth: This is a game of survival, and the key is mitigating […]
Scientists Worldwide Feverishly Working to Develop New Drug and Vaccine Candidates for COVID-19 Crisis
Palm Beach, FL – April 23, 2020 – America’s biopharmaceutical companies have recently reiterated that they are committed to developing solutions to help diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus. In addition to applying their scientific expertise to find ways to diagnose, treat and prevent infections from […]
ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research
Merimepodib is shown to decrease viral production of COVID-19 coronavirus more than remdesivir at clinically meaningful drug concentrations in pre-clinical testing. Article highlights recent work done in laboratory studies of COVID-19 with merimepodib at the Galveston National Laboratory at The University of Texas Medical Branch Westport, CT – April 23, 2020 – […]
Orphan Drug Act Fueling $200 Billion Dollar Market
Palm Beach, FL – April 23, 2020 – The Orphan Drug Designation program provides orphan status to drugs and biologics which are defined as those intended for the treatment, prevention or diagnosis of a rare disease or condition, which is one that affects less than 200,000 persons in the US or meets cost recovery provisions […]
